Mitochondrial Transfer in Cardiovascular Disease: From Mechanisms to Therapeutic Implications
Mitochondrial dysfunction has been proven to play a critical role in the pathogenesis of cardiovascular diseases. The phenomenon of intercellular mitochondrial transfer has been discovered in the cardiovascular system. Studies have shown that cell-to-cell mitochondrial transfer plays an essential ro...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a43529cd05964a74bf93745c4b7a6976 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:a43529cd05964a74bf93745c4b7a6976 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:a43529cd05964a74bf93745c4b7a69762021-12-01T05:48:01ZMitochondrial Transfer in Cardiovascular Disease: From Mechanisms to Therapeutic Implications2297-055X10.3389/fcvm.2021.771298https://doaj.org/article/a43529cd05964a74bf93745c4b7a69762021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fcvm.2021.771298/fullhttps://doaj.org/toc/2297-055XMitochondrial dysfunction has been proven to play a critical role in the pathogenesis of cardiovascular diseases. The phenomenon of intercellular mitochondrial transfer has been discovered in the cardiovascular system. Studies have shown that cell-to-cell mitochondrial transfer plays an essential role in regulating cardiovascular system development and maintaining normal tissue homeostasis under physiological conditions. In pathological conditions, damaged cells transfer dysfunctional mitochondria toward recipient cells to ask for help and take up exogenous functional mitochondria to alleviate injury. In this review, we summarized the mechanism of mitochondrial transfer in the cardiovascular system and outlined the fate and functional role of donor mitochondria. We also discussed the advantage and challenges of mitochondrial transfer strategies, including cell-based mitochondrial transplantation, extracellular vesicle-based mitochondrial transplantation, and naked mitochondrial transplantation, for the treatment of cardiovascular disorders. We hope this review will provide perspectives on mitochondrial-targeted therapeutics in cardiovascular diseases.Jun ChenJinjie ZhongLin-lin WangYing-ying ChenFrontiers Media S.A.articlecardiovascular diseasemitochondriamitochondrial transfermitochondrial transplantationtunneling nanotubesextracellular vesiclesDiseases of the circulatory (Cardiovascular) systemRC666-701ENFrontiers in Cardiovascular Medicine, Vol 8 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
cardiovascular disease mitochondria mitochondrial transfer mitochondrial transplantation tunneling nanotubes extracellular vesicles Diseases of the circulatory (Cardiovascular) system RC666-701 |
spellingShingle |
cardiovascular disease mitochondria mitochondrial transfer mitochondrial transplantation tunneling nanotubes extracellular vesicles Diseases of the circulatory (Cardiovascular) system RC666-701 Jun Chen Jinjie Zhong Lin-lin Wang Ying-ying Chen Mitochondrial Transfer in Cardiovascular Disease: From Mechanisms to Therapeutic Implications |
description |
Mitochondrial dysfunction has been proven to play a critical role in the pathogenesis of cardiovascular diseases. The phenomenon of intercellular mitochondrial transfer has been discovered in the cardiovascular system. Studies have shown that cell-to-cell mitochondrial transfer plays an essential role in regulating cardiovascular system development and maintaining normal tissue homeostasis under physiological conditions. In pathological conditions, damaged cells transfer dysfunctional mitochondria toward recipient cells to ask for help and take up exogenous functional mitochondria to alleviate injury. In this review, we summarized the mechanism of mitochondrial transfer in the cardiovascular system and outlined the fate and functional role of donor mitochondria. We also discussed the advantage and challenges of mitochondrial transfer strategies, including cell-based mitochondrial transplantation, extracellular vesicle-based mitochondrial transplantation, and naked mitochondrial transplantation, for the treatment of cardiovascular disorders. We hope this review will provide perspectives on mitochondrial-targeted therapeutics in cardiovascular diseases. |
format |
article |
author |
Jun Chen Jinjie Zhong Lin-lin Wang Ying-ying Chen |
author_facet |
Jun Chen Jinjie Zhong Lin-lin Wang Ying-ying Chen |
author_sort |
Jun Chen |
title |
Mitochondrial Transfer in Cardiovascular Disease: From Mechanisms to Therapeutic Implications |
title_short |
Mitochondrial Transfer in Cardiovascular Disease: From Mechanisms to Therapeutic Implications |
title_full |
Mitochondrial Transfer in Cardiovascular Disease: From Mechanisms to Therapeutic Implications |
title_fullStr |
Mitochondrial Transfer in Cardiovascular Disease: From Mechanisms to Therapeutic Implications |
title_full_unstemmed |
Mitochondrial Transfer in Cardiovascular Disease: From Mechanisms to Therapeutic Implications |
title_sort |
mitochondrial transfer in cardiovascular disease: from mechanisms to therapeutic implications |
publisher |
Frontiers Media S.A. |
publishDate |
2021 |
url |
https://doaj.org/article/a43529cd05964a74bf93745c4b7a6976 |
work_keys_str_mv |
AT junchen mitochondrialtransferincardiovasculardiseasefrommechanismstotherapeuticimplications AT jinjiezhong mitochondrialtransferincardiovasculardiseasefrommechanismstotherapeuticimplications AT linlinwang mitochondrialtransferincardiovasculardiseasefrommechanismstotherapeuticimplications AT yingyingchen mitochondrialtransferincardiovasculardiseasefrommechanismstotherapeuticimplications |
_version_ |
1718405496208097280 |